SCZM(SCZM)
SCZM
$9.65—Stale · unknown old
NASDAQ • Last print unknown ago
$9.65—Stale · unknown old
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $490M | $535M |
| Low | $470M | $514M |
| High | $509M | $556M |
| EBITDA Avg | $143M | $195M |
| Low | $138M | $187M |
| High | $148M | $202M |
| EBIT Avg | $111M | $152M |
| Low | $105M | $145M |
| High | $116M | $160M |
| Net Income Avg | $93M | $130M |
| Low | $88M | $123M |
| High | $98M | $137M |
| EPS Avg | $1.01 | $1.41 |
| Low | $0.96 | $1.34 |
| High | $1.06 | $1.48 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $118M | $131M |
| Low | $107M | $119M |
| High | $128M | $143M |
| EBITDA Avg | $33M | $41M |
| Low | $31M | $37M |
| High | $36M | $44M |
| EBIT Avg | $24M | $31M |
| Low | $22M | $28M |
| High | $27M | $35M |
| Net Income Avg | $21M | $27M |
| Low | $18M | $24M |
| High | $23M | $30M |
| EPS Avg | $0.22 | $0.28 |
| Low | $0.19 | $0.25 |
| High | $0.25 | $0.32 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |